Literature DB >> 7018684

Selective depolymerisation of heparin to produce radio-labelled substrates for sulfamidase, 2-acetamido-2-deoxy-alpha-D-glucosidase, acetyl-CoA:2-amino-2-deoxy-alpha-D-glucoside N-acetyltransferase, and 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase.

J J Hopwood, H Elliott.   

Abstract

Heparin was carboxyl-reduced with NaBT4, and degraded under conditions of acid hydrolysis that selectively cleaved the 2-0-sulfo-L-idopyranosidic linkages. The resulting, radiolabelled-disaccharides and -tetrasaccharides were isolated by gel chromatography, and then fractionated by ion-exchange chromatography, paper chromatography, and paper electrophoresis. Of the nine disaccharides isolated and identified, eight were probably derived from the major repeating-disaccharide unit in heparin (2-deoxy-2-sulfoamino-D-glucosyl 6-sulfate leads to L-idosyluronic acid 2-sulfate). Sodium borotritide reduction and/or HNO2 deamination of these eight disaccharide fractions indicated four to contain L-idopyranose residues and the other four to contain 1,6-anhydro-L-idopyranose residues as terminal units. The latter, terminal unit probably represents a minor component formed during the acid hydrolysis. On the basis of N-acetylation, N-sulfation, and HNO2-deamination studies, and the known positions and configurations of the glycosidic and sulfate linkages in heparin, four disaccharides were identified as 0-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-(1 leads to 4)-L-[6-3H]idopyranose, 0-(2-amino-2-deoxy-alpha-D-glycopyranosyl)-(1 leads to 4)-L-[6-3H]idopyranose 2-sulfate, and 0-(2-amino-2-deoxy-alpha-D-glucopyranosyl 6-sulfate]-(1 leads to 4)-L-[6-3H]idopyranose 2-sulfate. A similar set of four disaccharides contained 1,6-anhydro-L-[6-3H]idopyranose residues in place of the L-[6-3H]idopyranose residues. The other disaccharide was tentatively identified as 0-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-(1 leads to 4)-L-[6-3H]idopyranose, the isolation of which suggests the presence of an IdA(OSO-3)-GlcNAc-IdA(OSO-3) sequence in the heparin preparation, which accounts for at least 1% of its total sequence. The tetrasaccharides were fractionated, on the basis of their sulfate content, into at least five species by ion-exchange chromatography or by paper electrophoresis. These were fractionated further into species with and without carboxyl groups, and with L-idopyranose or 1,6-anhydro-L-idopyranose residues as terminal units. Tentative structures for some of these tetrasaccharides are proposed. Disaccharide and tetrasaccharide species were evaluated before and after N-acetylation or N-sulfation, as substrates for sulfamidase, acetyl-CoA: 2-amino-2-deoxy-alpha-D-glucoside N-acetyl-transferase, 2-acetamido-2-deoxy-alpha-D-glucosidase, or 2-acetamido-2-deoxy-D-glucose 6-sulfate sulfatase in human-skin fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018684     DOI: 10.1016/s0008-6215(00)86029-2

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  10 in total

1.  New substrates and enzyme assays for the detection of mucopolysaccharidosis III (Sanfilippo Syndrome) types A, B, C, and D by tandem mass spectrometry.

Authors:  Brian J Wolfe; Farideh Ghomashchi; Tim Kim; Cynthia A Abam; Martin Sadilek; Rhona Jack; Jerry N Thompson; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Bioconjug Chem       Date:  2012-03-09       Impact factor: 4.774

2.  Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity.

Authors:  J J Hopwood; H Elliott; V J Muller; G T Saccone
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

3.  Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties.

Authors:  J Bielicki; C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

4.  Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

5.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

6.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization.

Authors:  C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

7.  Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development.

Authors:  Michelle J Boyle; Mark Skidmore; Benjamin Dickerman; Lynsay Cooper; Anthony Devlin; Edwin Yates; Paul Horrocks; Craig Freeman; Wengang Chai; James G Beeson
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

8.  The structure of chondroitin B lyase complexed with glycosaminoglycan oligosaccharides unravels a calcium-dependent catalytic machinery.

Authors:  Gurvan Michel; Kevin Pojasek; Yunge Li; Traian Sulea; Robert J Linhardt; Rahul Raman; Vikas Prabhakar; Ram Sasisekharan; Miroslaw Cygler
Journal:  J Biol Chem       Date:  2004-05-21       Impact factor: 5.157

9.  Human liver sulphamate sulphohydrolase. Determinations of native protein and subunit Mr values and influence of substrate agylcone structure on catalytic properties.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1986-02-15       Impact factor: 3.857

10.  Urinary excretion of sulphated N-acetylhexosamines in patients with various mucopolysaccharidoses.

Authors:  J J Hopwood; H Elliott
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.